Founded in 1999 as The Pulmonary Research Institute at the LungenClinic Grosshansdorf and acquired by Velocity Clinical Research in 2024, the experienced team at Velocity’s dedicated research site in Ahrensburg conducts clinical trials across a broad variety of indications, and specializes in pulmonary diseases. By developing strong working relationships with local communities and a robust patient database, Velocity’s Ahrensburg staff provides fast, accurate patient enrollment support, even for diverse populations.
Our Ahrensburg team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.
Now Enroling in Ahrensburg
Velocity is enroling participants for clinical trials in Ahrensburg for the following conditions:
- Asthma
- COPD
- Bronchiectasis
- Idiopathic pulmonary fibrosis and other interstitial lung diseases